Yes fundamentally glove this has strong demand atleast till next year but sentimentally it’s not as popular as it did due the supposedly “recovery” sentiment going on.
gloves may lose the star glitter but the price at this level is still a buy call for the smaller players. Analyst's believed supply is still short until end 2021 { but the asp may be lower than the current peak } × still adequate margin & profit fir the producers
Dr Fauci said Pfizer n Moderna vaccine can only last for a couple of weeks. First dose can last for 28 days and then the 2nd jab can last for 7-10 days only . So how leh? Every 2 months have to jab the vaccine, like that die lah....
Price drop thn say is karma hit glove , n laughing others for losing money in glove , this really show you are brainless & sour grapes , no matter what we did our decision in investing , and yes we did earn in glove , and now we lose for the time being , and so wat? Still better thn you cursing others to lose money just coz u dint invest in glove
Better buy now and don't miss the current price. It will go up eventually as demand is picking up once vaccination start and economy open up. All frontline services require and not just hospital. Huge growth potential for glove and many is eyeing for the venture.
Gloves business will continue to grow for the next few years . Healthcare environment had changed . There are tenths of public listed Directors and owners are diversifying parts of their business into glove, or we want to follow the thinking of those ikan bilis retailers in i3 , who think they are smarter than this business identities and timing the market ?
Previously Ruberex have 8 single former production line for Nitrile Glove, with annual production of 1 billion pcs, so each production line can produce average 125mil pcs per annum, or 342k pcs per day.
In Q4, the company has completed its new production line. The new production line is double former production line, with annual capacity of 300mil pcs per annual, or 820k pcs per day.
Total there will be 5 new production line, so 300mil x 5 line = additional 1.5bil per annual.This is why newspaper / analyst always said Ruberrex capacity has increase from 1bil to 2.5bil.
Hearb from a friend who active in glove exporting, he said the new production line in Ruberex are rolled out as per schedule. The commissioning of each production line are smooth. By Jan'2021, expected all 5 production line will be running at full capacity.
How long will vaccine-induced immunity last? Looks like no one knows but those in Pharmaceutical is trying to make a quick buck here.
Fresh from Reuters
There is no quick way to determine how long immunity to the SARS-CoV-2 virus will last, and researchers will need to monitor this closely in the coming months and years.
There have been some reports of reinfection and falling antibody levels months after an initial bout of COVID-19, but it is still unclear how prevalent reinfection is. And there are signs that the immune system preserves a memory of coronavirus infection in the form of specialized memory cells that could kick into action rapidly if the virus is encountered again. And vaccines, Altmann says, are deliberately designed to provoke strong responses from the immune system.
The Health Ministry released a statement in response to the public’s inquiry regarding a recent Reuter’s report on 4 December.
The report claimed that the US pharmaceutical giant Pfizer has had challenges to their raw material supply chain which will result in reduced quantities for the first batch of their Covid-19 vaccine.
Last but not least pls b informed. Our mother earth is too sick now with the prolong pollution in land, air and water. The killing and extinction of many animals species, more dangerous virus will appear after covid 19. Covid 20, 21, 22 etc. We will need more mask, vaccine n sop. Gd luck.
i keep buying only. Because i know glove still under supply till end of 2021. 1.65 now dont want buy....later all chase high high thaat time i will throw to you my shares.
KUALA LUMPUR (Dec 7): MY E.G. Services Bhd (MYEG) announced today that it has entered into a cooperation with Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. (Zhifei) to obtain Malaysian Halal certification for the Chinese biopharma company’s COVID-19 vaccine and to exclusively distribute the vaccine in Malaysia for a 3-year period.
In a statement today, MYEG said the two companies have signed a Memorandum of Understanding, agreeing to cooperate in conducting Phase 3 clinical trials of Zhifei’s vaccine in Malaysia and in achieving compliance to Halal status requirements to secure Halal certification from the Department of Islamic Development Malaysia (JAKIM).
MYEG said the commencement of Phase 3 trial will make Zhifei’s vaccine one of the first to undergo this final stage trial in Malaysia under the purview of the Ministry of Health.
Zhifei is a subsidiary of Chongqing Zhifei Biological Products Co., Ltd., which is listed on the Shenzhen Stock Exchange and has been engaged in the biological products industry since 2002, mainly the production of vaccines for human use. Zhifei is presently one of five Chinese companies conducting Phase 3 clinical trials of their COVID-19 vaccines in various parts of the world.
Upon successful completion of the Phase 3 trials, MYEG will be the sole distributor of the vaccine in Malaysia.
Since Nov 1, 2020, MYEG has been appointed by the Malaysian Ministry of Health to develop and operate the MySafeTravel digital health pass system to facilitate inbound travellers’ compliance to mandatory COVID-19 testing and quarantine requirements.
In addition, MYEG also operates a one-stop portal for the COVID-19 screening of workers in the country, which includes a data sharing collaboration with the Department of Labour of Peninsular Malaysia.
MYEG was last traded at RM1.81, valuing it at RM6.61 billion.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
night_shadow
261 posts
Posted by night_shadow > 2020-12-04 15:28 | Report Abuse
Yes fundamentally glove this has strong demand atleast till next year but sentimentally it’s not as popular as it did due the supposedly “recovery” sentiment going on.